David Hurley

Statistics

Publications

Citations

752

H-Index

Active since

1989

Affiliations

Endo Pharmaceuticals (United States)(Current)

Cosmetic Laser Dermatology

Cotton (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

University of Cincinnati

David Hurley is an author at Endo Pharmaceuticals (United States) specializing in collagenase therapy, medicine, and pneumococcal conjugate vaccination.

ORCID

Publications per year

1989–2022

Publications

Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers

Sylvia H. Yeh, Alejandra Gurtman, David Hurley et al. · PEDIATRICS · 2010 · 238 citations

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants

David Greenberg, Patricia Hoover, Timo Vesikari et al. · Vaccine · 2018 · 107 citations

Veterinary Medicine, Immunology, Pediatrics +14

Social Behavior in Public Space: An Analysis of Behavioral Adaptations to CCTV

Lorraine Mazerolle, David Hurley, Mitchell B. Chamlin · Security Journal · 2002 · 80 citations

Social Sciences, Psychology, Social Psychology +10

A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

Heather Platt, David Greenberg, Bruce Tapiéro et al. · The Pediatric Infectious Disease Journal · 2020 · 64 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

A dose ranging study of 2 different formulations of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants

Randall G. Rupp, David Hurley, Staci Grayson et al. · Human Vaccines & Immunotherapeutics · 2019 · 60 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmaceutics +17

1–5 of 15